Sphera Funds Management’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-4,979
Closed -$5.66M 81
2019
Q4
$5.66M Buy
+4,979
New +$5.41M 0.47% 49
2019
Q3
Sell
-5,790
Closed -$9.54M 84
2019
Q2
$9.54M Sell
5,790
-679
-10% -$1.17M 1.31% 19
2019
Q1
$13.2M Sell
6,469
-4,246
-40% -$7.48M 1.2% 16
2018
Q4
$13.8M Buy
10,715
+4,663
+77% +$7.15M 1.55% 15
2018
Q3
$11.4M Buy
6,052
+456
+8% +$942K 1.31% 15
2018
Q2
$11.4M Buy
+5,596
New +$12.8M 1.57% 16
2016
Q3
Sell
-3,088
Closed -$1.73M 112
2016
Q2
$1.73M Buy
3,088
+772
+33% +$437K 0.45% 64
2016
Q1
$1.27M Buy
+2,316
New +$1.42M 0.28% 73
2014
Q4
Sell
-4,123
Closed -$1.92M 134
2014
Q3
$1.92M Buy
+4,123
New +$1.9M 0.24% 91
2014
Q2
Sell
-4,434
Closed -$1.31M 100
2014
Q1
$1.31M Sell
4,434
-2,702
-38% -$819K 0.3% 72
2013
Q4
$1.94M Buy
+7,136
New +$1.99M 0.54% 51

Other funds holding BLUE

Sphera Funds Management's BLUE Position: Q1 2020 in Review

Sphera Funds Management sold out of bluebird bio (BLUE) in Q1 2020, closing a stake of 4,979 shares — an estimated $5.66M sold.

Sphera Funds Management first reported a position in BLUE in Q4 2013 and held it in 11 quarters. The position peaked at $13.8M in Q4 2018. 247 funds tracked by Wall St. Rank hold BLUE as of Q1 2020.

  • Sphera Funds Management reported no remaining bluebird bio position as of Q1 2020 after selling out during the quarter.
  • Sphera Funds Management sold 4,979 bluebird bio shares in Q1 2020, an estimated $5.66M.
  • Sphera Funds Management first reported a position in bluebird bio in Q4 2013 and held it in 11 quarters.
  • Sphera Funds Management's bluebird bio position peaked at $13.8M in Q4 2018.
  • 247 funds tracked by Wall St. Rank held bluebird bio as of Q1 2020.

Based on Sphera Funds Management's 13F filing for Q1 2020, filed 14 May 2020.